F
Filip Van den Bosch
Researcher at Ghent University
Publications - 227
Citations - 11471
Filip Van den Bosch is an academic researcher from Ghent University. The author has contributed to research in topics: Medicine & Ankylosing spondylitis. The author has an hindex of 48, co-authored 175 publications receiving 8567 citations. Previous affiliations of Filip Van den Bosch include Ghent University Hospital.
Papers
More filters
Journal ArticleDOI
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Désirée van der Heijde,Sofia Ramiro,Robert Landewé,Xenofon Baraliakos,Filip Van den Bosch,Alexandre Sepriano,Alexandre Sepriano,Andrea Regel,Adrian Ciurea,Hanne Dagfinrud,Maxime Dougados,Maxime Dougados,Floris A. van Gaalen,Pál Géher,Irene E. van der Horst-Bruinsma,Robert D. Inman,Merryn Jongkees,Uta Kiltz,Tore K Kvien,Pedro Machado,Helena Marzo-Ortega,Anna Molto,Anna Molto,Victoria Navarro-Compán,Salih Ozgocmen,Fernando Pimentel-Santos,John D. Reveille,Martin Rudwaleit,Martin Rudwaleit,J. Sieper,Percival D. Sampaio-Barros,Dieter Wiek,Jürgen Braun +32 more
TL;DR: The 2016 Assessment of SpondyloArthritis international Society-EULAR recommendations provide up-to-date guidance on the management of patients with axSpA and three overarching principles and 13 recommendations deal with surgery and spinal fractures.
Journal ArticleDOI
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec,Xenofon Baraliakos,Andreas Kerschbaumer,Maarten de Wit,Iain B. McInnes,Maxime Dougados,Jette Primdahl,Dennis McGonagle,Daniel Aletaha,Andra Balanescu,Peter V. Balint,Heidi Bertheussen,Wolf-Henning Boehncke,Gerd R Burmester,Juan D. Cañete,Nemanja Damjanov,Tue Wenzel Kragstrup,Tore K Kvien,Robert Landewé,Rik Lories,Helena Marzo-Ortega,Denis Poddubnyy,Santiago Rodrigues Manica,Georg Schett,Douglas J. Veale,Filip Van den Bosch,Désirée van der Heijde,Josef S Smolen +27 more
TL;DR: The updated recommendations provide stakeholders with an updated consensus on the pharmacological management of PsA, based on a combination of evidence and expert opinion.
Journal ArticleDOI
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen,Monika Schöls,Jürgen Braun,Maxime Dougados,Oliver FitzGerald,Dafna D. Gladman,Arthur Kavanaugh,Robert Landewé,Philip J. Mease,Joachim Sieper,Tanja Stamm,Maarten de Wit,Daniel Aletaha,Xenofon Baraliakos,Neil Betteridge,Filip Van den Bosch,Laura C. Coates,Paul Emery,Lianne S. Gensler,Laure Gossec,Philip S. Helliwell,Merryn Jongkees,Tore K Kvien,Robert D. Inman,Iain B. McInnes,Mara Maccarone,Pedro Machado,Anna Molto,Alexis Ogdie,Denis Poddubnyy,Christopher T. Ritchlin,Martin Rudwaleit,Adrian Tanew,Bing Thio,Douglas J. Veale,Kurt de Vlam,Désirée van der Heijde +36 more
TL;DR: There was broad agreement, now better supported by data than in 2012, that remission/inactive disease and, alternatively, low/minimal disease activity are the principal targets for the treatment of PsA.
Journal ArticleDOI
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Michael M. Ward,Atul Deodhar,Elie A. Akl,Andrew Lui,Joerg Ermann,Lianne S. Gensler,Judith A. Smith,David G. Borenstein,Jayme Hiratzka,Pamela F. Weiss,Robert D. Inman,Vikas Majithia,Nigil Haroon,Walter P. Maksymowych,Janet Joyce,Bruce M. Clark,Robert A. Colbert,Mark P. Figgie,David S. Hallegua,Pamela E. Prete,James T. Rosenbaum,Judith A. Stebulis,Filip Van den Bosch,David T. Y. Yu,Amy S. Miller,John D. Reveille,Liron Caplan +26 more
TL;DR: To provide evidence‐based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spONDyloarthritis (SpA).
Journal ArticleDOI
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S Smolen,Jürgen Braun,Maxime Dougados,Paul Emery,Oliver FitzGerald,Philip S. Helliwell,Arthur Kavanaugh,Tore K Kvien,Robert Landewé,Thomas A. Luger,Philip J. Mease,Ignazio Olivieri,John D. Reveille,Christopher T. Ritchlin,Martin Rudwaleit,Monika Schoels,Joachim Sieper,Martinus de Wit,Xenofon Baraliakos,Neil Betteridge,Ruben Burgos-Vargas,Eduardo Collantes-Estevez,Atul Deodhar,Dirk Elewaut,Laure Gossec,Merryn Jongkees,Mara Maccarone,Kurt Redlich,Filip Van den Bosch,James Cheng-Chung Wei,Kevin L. Winthrop,Désirée van der Heijde +31 more
TL;DR: The task force defined the treatment target for SpA as remission or, alternatively, low disease activity, being aware that the evidence base is not strong and needs to be expanded by future research.